Acquiring Company
Tavexia Lifecare
Acquired Company
Meyonex Pharmaceuticals
Description
Tavexia Lifecare has proposed to acquire a 60% stake in Meyonex Pharmaceuticals. This acquisition aims to strengthen Tavexia's presence in the pharmaceutical industry. The deal is expected to bring new opportunities for both companies involved.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tavexia Lifecare makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Trusted by
M&A Insights
Based on deal dataFrequently asked
Who acquired Meyonex Pharmaceuticals?
Meyonex Pharmaceuticals was acquired by Tavexia Lifecare. The deal was reported on September 19, 2026. Tavexia Lifecare is a company focused on healthcare and pharmaceutical developments. They aim to enhance patient care through innovative solutions. Tavexia Lifecare is privately held and operates in Biotechnology.
When did Tavexia Lifecare acquire Meyonex Pharmaceuticals?
Tavexia Lifecare's acquisition of Meyonex Pharmaceuticals was reported on September 19, 2026. Tavexia Lifecare has proposed to acquire a 60% stake in Meyonex Pharmaceuticals. This acquisition aims to strengthen Tavexia's presence in the pharmaceutical industry. The deal is expected to bring new opportunities for both companies involved. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Meyonex Pharmaceuticals do?
Meyonex Pharmaceuticals is a pharmaceutical company engaged in the development of various therapeutic drugs. They focus on delivering quality medications to enhance health outcomes. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.